Table 2 Basal ganglia metabolites ratios in both groups
From: Brain magnetic resonance spectroscopy and cognitive impairment in chronic hepatitis C patients
|  | Group without cognitive impairment Mean ± SD (N = 23) | Group with cognitive impairment Mean ± SD (N = 23) | p value | |
|---|---|---|---|---|
BG | Glu/Cr | 0.45 ± 0.09 | 0.46 ± 0.10 | 0.784 NSα |
CHO/Cr | 0.89 ± 0.14 | 1.00 ± 0.10 | 0.000 *α | |
MI/Cr | 0.51 ± 0.10 | 0.55 ± 0.09 | 0.122 NSα | |
NAA/CHO | 1.86 ± 0.36 | 1.83 ± 0.30 | 0.854 NSα | |
NAA/Cr | 1.59 ± 0.39 | 1.39 ± 0.31 | 0.011 *α | |